Brain Biomarkers of some Egyptian Children with Autism manifesting poor language development
Paper Details
Brain Biomarkers of some Egyptian Children with Autism manifesting poor language development
Abstract
Autism is characterized by deficits in social interaction with restricted repetitive patterns of interests during the early developmental period. Alterations of some biochemical measures were suspected to have a role in autism pathogenesis such as dopamine, serotonin and brain-derived neurotrophic factor. These measures are important for the development of memory, language and social abilities. Hence, they could be altered in autism. We aimed to measure the blood levels of dopamine, serotonin and brain-derived neurotrophic factor in a group of Egyptian autistic children with language impairment in comparison to healthy control children to investigate the relation between them. The study included 40 children with autism and 20 healthy controls. The autism and language delay were diagnosed according to the diagnostic and statistical manual of mental disorders. The dopamine and serotonin levels for both groups were determined by high-performance liquid chromatography. The brain-derived neurotrophic factor was measured by ELISA. The level of dopamine in the autism group was less than that in the control group while the brain-derived neurotrophic factor level was higher in the autism group. Investigating the relation between dopamine and the brain-derived neurotrophic factor in the autism group revealed a statistically significant positive correlation (r=0.5, p<0.01). In conclusion, the dopamine and the brain-derived neurotrophic factor could have a role in the pathogenesis of autism. These measures could be used as diagnostic biomarkers for children suspected to have autism.
Abu-Hasseba A. 2011. Standardization translation and modification of the preschool language scale-4. MD thesis of phoniatrics. Cairo, Egypt: Faculty of medicine, Ain Shams University.
American Psychiatric Association. 2013. Diagnostic and statistical manual of mental disorders, 5th ed. American Psychiatric Association. Arlington, VA. http://dx.doi.org/10.1176/appi.books.9780890425.596
American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association. Washington DC.
Anderson BM, Schnetz-Boutaud NC, Bartlett J, Wotawa AM, Wright HH, Abramson RK. 2009. Examination of association of genes in the serotonin system to autism. Neurogene 10(3), 209-16. http://dx.doi.org/10.1007/s10048-009-0171-7
Bello-Mojeed MA, Omigbodun OO, Bakare MO, Adewuya AO. 2017. Pattern of impairments and late diagnosis of autism spectrum disorder among a sub-Saharan African clinical population of children in Nigeria. Global Mental Health (Camb). 4, e5. http://dx.doi.org/10.1017/gmh.2016.30
Boddaert N, Chabane N, Belin P, Bourgeois M, Royer V, Barthelemy C, Mouren-Simeoni MC, Philippe A, Brunelle F, Samson Y, Zilbovicius M. 2004. Perception of complex sounds in autism: abnormal auditory cortical processing in children. The American Journal of Psychiatry 161(11), 2117-20. http://dx.doi.org/10.1176/appi.ajp.161.11.2117
Borodinova AA, Salozhin SV. 2017. Differences in the Biological Functions of BDNF and proBDNF in the Central Nervous System. Neuroscience and Behavioral Physiology volume 47(3), 251-265. http://dx.doi.org/10.1007/s11055-017-0391-5
Careaga M, Rogers S, Hansen RL, Amaral DG, Ashwood P. 2017. Immune endophenotypes in children with autism spectrum disorder. Biological Psychiatry 81(5), 434-441. http://dx.doi.org/10.1016/j.biopsych.2015.08.036
Cartier E, Hamilton PJ, Belovichd AN, Shekard A, Campbellb NG, Saundersd C, Andreassen TF. 2015. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (hDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine 2(2), 135-146. http://dx.doi.org/10.1016/j.ebiom.2015.01.007.
Cathomas F, Vogler C, Euler-Sigmund JC, de Quervain DJ, Papassotiropoulos A. 2010. Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory. International Journal of Neuropsychopharmacology 13(8), 975-80. http://dx.doi.org/10.1017/S1461145710000519
Chugani DC. 2011. Neurotransmitters. In: Amaral, Dawson ve Geshwind (ed) Autism spectrum disorders. Oxford University Press, Oxford, UK.
Cooper RA, Richter FR, Bays PM, Plaisted-Grant KC, Simon Baron-Cohen S, Simons JS. 2017. Reduced Hippocampal Functional Connectivity During Episodic Memory Retrieval in Autism. Cerebral Cortex 27(2), 888–902. http://dx.doi.org/10.1093/cercor/bhw417
da Costa RO, Gadelha-Filho C, da Costa A, Feitosa M, de Araújo D, de Lucena J, de Aquino PEA, Lima FAV, Neves KRT, de Barros Viana GS. 2017. The treadmill exercise protects against dopaminergic neuron loss and brain oxidative stress in parkinsonian rats. Oxidative Medicine and Cellular Longevity 2138169. http://dx.doi.org/10.1155/2017/2138169.
Duff MC, Brown-Schmidt S. 2012. The hippocampus and the flexible use and processing of language. Frontiers in Human Neuroscience 6, 69. http://dx.doi.org/10.3389/fnhum.2012.000.69
Hussein J, El-Matty DA, El-Khayat Z, Abdel-Latif Y. 2012. Brain neurotransmitters in diabetic rats treated with coenzyme Q10. International Journal of Pharmacy and Pharmaceutical Sciences 4(4), 554-556.
Kriete T, Noelle D. 2015. Dopamine and the development of executive dysfunction in autism spectrum disorders. PLoS One 10(3), e0121605. http://dx.doi.org/10.1371/journal.pone.01216.05
Lainhart JE, Lange N. 2011. Increased neuron number and head size in autism. JAMA. 306(18), 2031-2. http://dx.doi.org/10.1001/jama.2011.1633
Mannion A, Leader G. 2016. An investigation of comorbid psychological disorders, sleep problems, gastrointestinal symptoms and epilepsy in children and adolescents with autism spectrum disorder: A two-year follow-up. Research in Autism Spectrum Disorders 22, 20-33. http://dx.doi.org/10.1016/j.rasd.2015.11.002
Meguid NA, Nashaat NH, Hashem HS, Khalil MM. 2018. Frequency of risk factors and coexisting abnormalities in a population of Egyptian children with autism spectrum disorder. Asian Journal of Psychiatry 32, 54-58. http://dx.doi.org/10.1016/j.ajp.2017.11.037
Meltzer A, Van de Water J. 2017. The Role of the Immune System in Autism Spectrum Disorder. Neuropsychopharmacology 42(1), 284-298. http://dx.doi.org/10.1038/npp.2016.15.8
Mick KA. 2005. Diagnosing Autism: Comparison of the Childhood Autism Rating Scale (CARS) and the Autism Diagnostic Observation Schedule (ADOS). PhD Dissertation. Kansas: Wichita State University.
Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N, Narita M. 2004. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain and Development 26(5), 292-295. http://dx.doi.org/10.1016/S0387-7604(03)00168-2.
Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T. 2003. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119(3), 767-75. http://dx.doi.org/10.1016/s0306-4522(03)00099-x.
Pavăl D. 2017. A Dopamine Hypothesis of Autism Spectrum Disorder. Developmental Neuroscience 39, 355-360. http://dx.doi.org/10.1159/000478725
Quaak I, Brouns MR, Van de Bor M. 2013. The Dynamics of autism spectrum disorders: how neurotoxic compounds and neurotransmitters interact. International Journal of Environmental Research and Public Health 10(8), 3384–3408. http://dx.doi.org/10.3390/ijerph100833.84
Ramoz N, Reichert JG, Corwin TE, Smith CJ, Silverman JM, Hollander E, Buxbaum JD. 2006. Lack of evidence for association of the serotonin transporter gene SLC6A4 with autism. Biol Psychiatry 60(2), 186-91. http://dx.doi.org/10.1016/j.biopsych.2006.01.009.
Roid GH. 2003. Stanford-Binet intelligence scales. Riverside Pub., http://journals.sagepub.com/doi/abs/10.1177/08295735040190011311.
Saleh M, Nashaat NH, Fahim C, Ibrahim AS, Meguid N. 2015. MRI surface-based brain morphometry in Egyptian autistic and typically developing children. Folia Phoniatrica et Logopaedica 67(1), 29-35. http://dx.doi.org/10.1159/000368962.
Schauder KB, Muller CL, Veenstra-Vander Weele J, Cascio CJ. 2015. Genetic variation in serotonin transporter modulates tactile hyperresponsiveness in ASD. Research in Autism Spectrum Disorders 10, 93–100. http://dx.doi.org/10.1016/j.rasd.2014.11.008.
Scholper E, Van Bourgondien ME, Wellman GJ, Love SR. 2010. Childhood Autism Rating Scale-(CARS2). Los Angeles, CA: Western Psychological Services, p 658.
Sperdin HF, Schaer M. 2016. Aberrant Development of Speech Processing in Young Children with Autism: New Insights from Neuroimaging Biomarkers. Frontiers in Neuroscience 10,393. http://dx.doi.org/10.3389/fnins.2016.00393.
Toichi M. Kamio Y. 2003. Long-term memory in high-functioning autism: controversy on episodic memory in autism reconsidered. Journal of Autism and Developmental Disorders 33(2), 151-161. http://dx.doi.org/10.1023/A:1022935325843
Weismer SE, Lord C, Esler A. 2010. Early language patterns of toddlers on the autism spectrum compared to toddlers with developmental delay. Journal of Autism and Developmental Disorders 40(10), 1259-1273. http://dx.doi.org/10.1007/s10803-010-0983-1
Abdelrahman A. Ramadan, Zakaria El-Khayat, Shadia A. Fathy, Ehab Ragaa Abdelraouf, Marwa G.A. Hegazy (2020), Brain Biomarkers of some Egyptian Children with Autism manifesting poor language development; IJB, V17, N6, December, P276-286
https://innspub.net/brain-biomarkers-of-some-egyptian-children-with-autism-manifesting-poor-language-development/
Copyright © 2020
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0